Bi Y - Search Results

1

A role for Rho and Rac in secretagogue-induced amylase release by pancreatic acini.

Bi Y, Williams JA. Bi Y, et al. Am J Physiol Cell Physiol. 2005 Jul;289(1):C22-32. doi: 10.1152/ajpcell.00395.2004. Epub 2005 Mar 2. Am J Physiol Cell Physiol. 2005. PMID: 15743890 Free article.

2

CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini.

Sabbatini ME, Bi Y, Ji B, Ernst SA, Williams JA. Sabbatini ME, et al. Among authors: bi y. Am J Physiol Cell Physiol. 2010 Mar;298(3):C592-601. doi: 10.1152/ajpcell.00448.2009. Epub 2009 Nov 25. Am J Physiol Cell Physiol. 2010. PMID: 19940064 Free PMC article.

3

CCK-A receptor activates RhoA through G alpha 12/13 in NIH3T3 cells.

Le Page SL, Bi Y, Williams JA. Le Page SL, et al. Among authors: bi y. Am J Physiol Cell Physiol. 2003 Nov;285(5):C1197-206. doi: 10.1152/ajpcell.00083.2003. Epub 2003 Jul 9. Am J Physiol Cell Physiol. 2003. PMID: 12853286 Free article.

4

Rho and Rac promote acinar morphological changes, actin reorganization, and amylase secretion.

Bi Y, Page SL, Williams JA. Bi Y, et al. Am J Physiol Gastrointest Liver Physiol. 2005 Sep;289(3):G561-70. doi: 10.1152/ajpgi.00508.2004. Epub 2005 May 26. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15920016 Free article.

5

Receptor biology and signal transduction in pancreatic acinar cells.

Bi Y, Williams JA. Bi Y, et al. Curr Opin Gastroenterol. 2004 Sep;20(5):427-34. doi: 10.1097/00001574-200409000-00002. Curr Opin Gastroenterol. 2004. PMID: 15689674

6

Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin.

Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD. Ji B, et al. Among authors: bi y. Gastroenterology. 2001 Dec;121(6):1380-90. doi: 10.1053/gast.2001.29557. Gastroenterology. 2001. PMID: 11729117

7

Human pancreatic acinar cells do not respond to cholecystokinin.

Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD. Ji B, et al. Among authors: bi y. Pharmacol Toxicol. 2002 Dec;91(6):327-32. doi: 10.1034/j.1600-0773.2002.910610.x. Pharmacol Toxicol. 2002. PMID: 12688376 Free article. Review.

8

Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium.

Gonda TA, Farrell J, Wallace M, Khanna L, Janec E, Kwon R, Saunders M, Siddiqui UD, Brand R, Simeone DM; PRECEDE Consortium. Gonda TA, et al. Gastrointest Endosc. 2022 Apr;95(4):723-732.e7. doi: 10.1016/j.gie.2021.10.025. Epub 2021 Nov 2. Gastrointest Endosc. 2022. PMID: 34736932

9

Pancreas-specific CHRM3 activation causes pancreatitis in mice.

Wan J, Wang J, Wagner LE 2nd, Wang OH, Gui F, Chen J, Zhu X, Haddock AN, Edenfield BH, Haight B, Mukhopadhyay D, Wang Y, Yule DI, Bi Y, Ji B. Wan J, et al. Among authors: bi y. JCI Insight. 2021 Sep 8;6(17):e132585. doi: 10.1172/jci.insight.132585. JCI Insight. 2021. PMID: 34314386 Free PMC article.

10

Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth.

Zhang Y, Ma Y, Wang Y, Mukhopadhyay D, Bi Y, Ji B. Zhang Y, et al. Among authors: bi y. Pancreatology. 2022 Jun;22(5):619-625. doi: 10.1016/j.pan.2022.03.019. Epub 2022 Apr 13. Pancreatology. 2022. PMID: 35550115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,919 results

Search Page